Effectiveness and tolerance of multicorrective topical treatment for infraorbital dark circles and puffiness
Journal of Cosmetic Dermatology · 2024
DOI: 10.1111/jocd.16122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Ali Rajabi-Estarabadi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Broward health, Fort Lauderdale, Florida, USA. Hauptthemen laut MEDLINE: Pigmentation Disorders, Hyperpigmentation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Revision Skincare.
Abstract (Originalsprache)
Background
Treatment of infraorbital dark circles and under‐eye puffiness is challenging due to its multifactorial nature and lack of broadly applicable, effective treatments. A daily skincare treatment option that is multimodal, effective, and tolerable across a broad patient population is an unmet need.
Aim
A multicorrective topical eye cream (MTEC) formulated with Tetrahexyldecyl (THD) ascorbate (vitamin C), prebiotic Inula Helenium , bioavailable peptides, botanical extracts, chrysin, and caffeine is hypothesized to improve the appearance of infraorbital dark circles and under‐eye puffiness by targeting microvasculature congestion and permeability, melanin accumulation and hemoglobin degradation‐related pigmentation, and skin health.
Methods
An IRB approved, open‐label, 12‐week clinical study set out to evaluate the efficacy and tolerability of the MTEC across a broad patient population including varying ethnicities and Fitzpatrick Skin Types (FST). Female subjects ( n = 40) ages 35–60 years old, with moderate‐to‐severe under‐eye dark circles, moderate under‐eye puffiness, and mild‐to‐moderate fine lines were enrolled into the study.
Objective
(Chromameter, VISIA® imaging, and Laser Doppler) and subjective assessments (clinical grading and self‐assessment questionnaire) were conducted at baseline and post‐baseline timepoints.
Results
Thirty‐seven subjects completed the study, and the MTEC efficaciously demonstrated short‐term and long‐term improvements in objective and subjective assessments across a broad patient population. Specifically, the MTEC demonstrated significant improvement of infraorbital dark circles, mainly by the reduction in microvasculature congestion and permeability, melanin, and hemoglobin degradation‐related pigmentation.
Conclusion
Topical application of the MTEC may offer an effective and tolerable treatment option for infraorbital dark circles and puffiness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Broward health, Fort Lauderdale, Florida, USA.
- Skin Wellness Dermatology, Birmingham, Alabama, USA.
- Revision Skincare®, Irving, Texas, USA.
ORCID-Profile: Alisar S Zahr
Förderung
- Revision Skincare
Zitieren
APA
Rajabi-Estarabadi, A., Hartman, C. L., Iglesia, S., Kononov, T., & Zahr, A. S. (2024). Effectiveness and tolerance of multicorrective topical treatment for infraorbital dark circles and puffiness. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16122
Vancouver
Rajabi-Estarabadi A, Hartman CL, Iglesia S, Kononov T, Zahr AS. Effectiveness and tolerance of multicorrective topical treatment for infraorbital dark circles and puffiness. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16122
BibTeX
@article{RajabiEstarabadi2024,
author = {Rajabi-Estarabadi, Ali and Hartman, Corey L and Iglesia, Sofia and Kononov, Tatiana and Zahr, Alisar S},
title = {Effectiveness and tolerance of multicorrective topical treatment for infraorbital dark circles and puffiness},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
doi = {10.1111/jocd.16122}
}
EUVIMED